Tempest Therapeutics's total assets for Q3 2024 were $33.84M, a decrease of -19.76% from the previous quarter. TPST total liabilities were $22.38M for the fiscal quarter, a -11.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.